Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Wiwynn Corp
Astera Labs Announces Financial Results for the Third Quarter of Fiscal Year 2025
Business
Nov 4 2025
21 min read

Astera Labs Announces Financial Results for the Third Quarter of Fiscal Year 2025

news images
  • Record quarterly revenue of $230.6 million, up 20% QoQ and 104% YoY

  • Strong Q3 revenue growth driven by new AI platform ramps featuring multiple product families

  • Scorpio fabric switch design wins expand to several platforms at multiple hyperscaler customers

SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced preliminary financial results for the third quarter of fiscal year 2025, ended September 30, 2025.

“Astera Labs delivered strong financial results in Q3 with revenue growing by 20% sequentially to a new record level of $230.6 million,” said Jitendra Mohan, Astera Labs’ Chief Executive Officer. “During the quarter, we saw robust demand and upside across our signal conditioning, smart cable module (SCM), and switch fabric portfolios as new AI platforms ramped up production. Looking into Q4, we anticipate continued PCIe 6 momentum alongside robust growth from our Taurus Ethernet SCMs. We remain focused on our rack-scale vision, which is further strengthened by the proposed acquisition of aiXscale Photonics, which we believe will support our customers' technology roadmaps and increase our market reach beyond copper interconnects.”

Third Quarter 2025 Financial Highlights

GAAP Financial Results:

  • Revenue of $230.6 million, up 20% sequentially and up 104% year-over-year

  • GAAP gross margin of 76.2%

  • GAAP operating income of $55.4 million

  • GAAP operating margin of 24.0%

  • GAAP net income of $91.1 million

  • GAAP diluted earnings per share of $0.50

Non-GAAP Financial Results (excluding the impact of stock-based compensation expense and the income tax effects of non-GAAP adjustments):

  • Non-GAAP gross margin of 76.4%

  • Non-GAAP operating income of $96.1 million

  • Non-GAAP operating margin of 41.7%

  • Non-GAAP net income of $88.2 million

  • Non-GAAP diluted earnings per share of $0.49

Q3 2025 and Recent Business Highlights

  • Entered into a definitive agreement to acquire aiXscale Photonics GmbH, a provider of fiber-chip coupling technologies. The evolution to AI Infrastructure 2.0 demands scale-up connectivity solutions that meet aggressive speed, power, reach, and reliability requirements while facilitating high-volume, rack-scale integration. Optical connectivity will be critical to supporting the massive bandwidth needs of scale-up systems with hundreds of accelerators. The acquisition will help enable Astera Labs to develop photonic scale-up solutions by combining aiXscale’s fiber-chip coupling capabilities with Astera Labs’ connectivity and signal processing expertise.

  • Showcased our AI rack-scale vision with a full portfolio of purpose-built connectivity solutions at the 2025 Open Compute Project (OCP) Global Summit built across a multitude of open standards including PCIe, UALink, Ethernet, CXL, and OpenBMC. Live demos highlighted state-of-the-art silicon, hardware, and software solutions enabling an open and collaborative ecosystem for optimizing rack-scale performance and flexibility. Our experts also delivered six technical sessions on topics including UALink deployment strategies and PCIe security.

  • Announced new comprehensive collaborations spanning GPU, CPU, cables, connectors, ODMs, IP design and verification, and software management providers to accelerate AI Infrastructure 2.0 deployment through open standards. Collaborations with AMD, Amphenol, Arm, ASPEED, Cadence Design Systems, Eoptolink, Ingrasys, Insyde Software, Molex, Quanta Computer, Synopsys, TE Connectivity, Wistron, and Wiwynn are driving rack-scale innovation with an open ecosystem.

  • Joined Arm Total Design to accelerate and simplify custom SoC development based on Arm Neoverse Compute Subsystems (CSS). As a key design services partner, Astera Labs will provide multi-protocol chiplet solutions via its proven Intelligent Connectivity Platform. The collaboration enables customers to build platform-specific AI infrastructure with validated, interoperable connectivity solutions.

Fourth Quarter of Fiscal 2025 Financial Outlook

Based on current business trends and conditions, Astera Labs estimates the following:

GAAP Financial Outlook:

  • Revenue within a range of $245 million to $253 million

  • GAAP gross margin of approximately 75%

  • GAAP operating expenses within a range of approximately $129 million to $134 million

  • GAAP tax rate of approximately 45%

  • GAAP diluted earnings per share of approximately $0.20 weighted-average diluted shares outstanding of approximately 183 million

Non-GAAP Financial Outlook (excluding the impact of stock-based compensation expense and the income tax effects of non-GAAP adjustments):

  • Non-GAAP gross margin of approximately 75%

  • Non-GAAP operating expenses within a range of approximately $85 million to $90 million

  • Non-GAAP tax rate of approximately 15%

  • Non-GAAP diluted earnings per share of approximately $0.51 on non-GAAP weighted-average diluted shares outstanding of approximately 183 million

Earnings Webcast and Conference Call
Astera Labs will host a conference call to review its financial results for the third quarter of fiscal 2025 and to discuss our financial outlook today at 1:30 p.m. Pacific Time. Interested parties may join the conference call by dialing 1-800-715-9871 and using conference ID 5908687. The call will also be webcast and can be accessed at the Astera Labs website at https://ir.asteralabs.com/. The webcast will be recorded and available for replay on the company’s website for the next six months.

Discussion of Non-GAAP Financial Measures
We use certain non-GAAP financial measures, including those concerning our financial outlook, to supplement the performance measures in our consolidated financial statements, which are presented in accordance with GAAP. A reconciliation of these non-GAAP measures to the closest GAAP measure can be found later in this release. The timing and impact of any adjustments to arrive at the corresponding GAAP financial measures concerning our financial outlook are inherently dependent on future events that are typically uncertain or that may be outside of our control. These non-GAAP financial measures include non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating margin, non-GAAP tax rate, non-GAAP net income, non-GAAP pro forma diluted earnings per share, and non-GAAP pro forma weighted-average share count. We use these non-GAAP financial measures for financial and operational decision-making and as a means to assist us in evaluating period-to-period comparisons. By excluding certain items that may not be indicative of our recurring core operating results, we believe that, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP operating margin, non-GAAP tax rate, non-GAAP net income, non-GAAP pro forma diluted earnings per share, and non-GAAP pro forma weighted-average share count provide meaningful supplemental information regarding our performance. Accordingly, we believe these non-GAAP financial measures are useful to investors and others because they allow for additional information with respect to financial measures used by management in its financial and operational decision-making and they may be used by our institutional investors and the analyst community to help them analyze the health of our business. However, there are a number of limitations related to the use of non-GAAP financial measures, and these non-GAAP measures should be considered in addition to, not as a substitute for or in isolation from, our financial results prepared in accordance with GAAP. Other companies, including companies in our industry, may calculate these non-GAAP financial measures differently or not at all, which reduces their usefulness as comparative measures.

We adjust the following items from one or more of our non-GAAP financial measures:

Stock-based compensation expense
We exclude stock-based compensation expense, which is a non-cash expense, from certain of our non-GAAP financial measures because we believe that excluding this item provides meaningful supplemental information regarding operational performance. In particular, companies calculate non-cash stock-based compensation expense using a variety of valuation methodologies and subjective assumptions. Moreover, stock-based compensation expense is a non-cash charge that can vary significantly from period to period for reasons that are unrelated to our core operating performance, and therefore excluding this item provides investors and other users of our financial information with information that allows meaningful comparisons of our business performance across periods.

Employer payroll taxes related to stock-based compensation resulting from our IPO
We exclude employer payroll taxes related to the time-based vesting and net settlement of restricted stock units in connection with our initial public offering (the “IPO”), because this does not correlate to the operation of our business. We believe that excluding this item provides meaningful supplemental information regarding operational performance given the amount of employer payroll tax-related items on employee stock transactions was immaterial prior to our IPO.

Income tax effect
This represents the impact of the non-GAAP adjustments on an after-tax basis and one-off discrete tax adjustments that are unrelated to our core operating performance in connection with the presentation of non-GAAP net income and non-GAAP net income per diluted share. This approach is designed to enhance investors’ ability to understand the impact of our non-GAAP tax expense on our current operations, provide improved modeling accuracy, and substantially reduce fluctuations caused by GAAP to non-GAAP adjustments.

Non-GAAP pro forma weighted-average shares to compute non-GAAP pro forma net income per share
We present non-GAAP pro forma weighted-average shares, assuming our redeemable convertible preferred stock is converted from the beginning of each respective periods presented, to provide meaningful supplemental information regarding EPS trend on a consistent basis. All of our outstanding redeemable preferred stock converted into the equivalent number of shares of common stock in connection with our IPO.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements based on Astera Labs' current expectations. The words “accelerating,” “advance,” “aims,” “anticipate,” “beginning,” “believe," “confidence,” “committed,” “continue,” “deliver,” “designed,” “enable,” “estimate," “expand,” “expect," “forecasting,” “forthcoming,” “goal,” “guidance,” “intend," “look,” “may,” “momentum,” “strategies,” “on track,” “opportunities,” “positioning,” “progress,” “proliferate,” “proposed,” “prospects,” “provide,” “represents,” “roadmaps,” “should,” “upside,” “vision,” “will,” and similar phrases as they relate to Astera Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Astera Labs as of November 4, 2025, and are subject to various assumptions, beliefs, risks and uncertainties that could cause actual results to differ materially from expectations. These forward-looking statements include, but are not limited to, statements regarding our future business, operating results, cash flow, financial position and guidance (and any underlying drivers), including for the fourth quarter of fiscal 2025; our business strategy, plans and market opportunities, our growth profile and our ability to further build upon our revenue base, expand our product offerings, increase our market opportunity, remain at the forefront of an AI infrastructure transformation, and scale our connectivity platform; our objectives for future operations; our production, development, shipping and delivery of, activity, applications and demand for, availability of, as well as absolute and relative revenue and growth (including the drivers) from, existing, new, growing or enhanced products, including continued expansion of PCIe 6 connectivity deployments into custom ASIC accelerator-based systems, growth of Ethernet SCMs across multiple 400G applications and continued wins for our Scorpio product family with hyperscaler customers and the performance and results of those products for our customers; the timing, impact and proliferation of different connectivity standards and demands; the plans and potential success of our announced and ongoing collaborations, partnerships and strategic relationships, including our Arm Total Design collaboration and the set of comprehensive collaborations spanning GPU, CPU, cables & connectors, ODM, software management, and IP/design & verification providers announced at the 2025 OCP; our competitive positioning and the impacts thereof; our R&D and strategic IP plans; our timing and ability to complete the acquisition of aiXscale Photonics and develop photonic scale-up solutions, and the anticipated effects and benefits associated with the acquisition; the size of our team; and maximize and future industry and macroeconomic conditions, events and trends such as in cloud and AI infrastructure as well as our preparedness and solutions for them. A variety of risks and factors that are beyond our control could cause actual results to differ materially from those in the forward-looking statements including, without limitation: the competitive and cyclical nature of the semiconductor industry; the concentration of our customer base; the changes in demand for AI; the macroeconomic and/or geopolitical environment, including economic uncertainty and volatility in the capital markets; risks that demand for our products and the supply chain may be adversely affected, including by the imposition of tariffs by the United States or any other jurisdiction and any corresponding retaliatory tariffs, changes in political policies, military conflict (such as between Russia/Ukraine and Israel/Hamas), terrorism, sanctions or other geopolitical events globally (including conflict between Taiwan and China); quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with managing international activities (including trade barriers, particularly with respect to China); our ability to successfully complete acquisitions and to integrate newly acquired businesses and offerings; absence of long-term commitments from customers; risks that Astera Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; stock price volatility; information technology risks, including cyber-attacks against Astera Labs' products and its networks; and other risks and uncertainties that are detailed under the caption “Risk Factors” and elsewhere in our Annual Report on 10-K, as filed with the Securities and Exchange Commission (the “SEC”) on February 14, 2025, and in subsequent Quarterly Reports on Form 10-Q filed with the SEC and the other SEC filings and reports Astera Labs may make from time to time.  Moreover, we operate in a very competitive and rapidly changing environment, and new risks may emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor(s) may cause actual results or outcomes to differ materially from those contained in any forward-looking statements we may make. Accordingly, you should not unduly rely on any of the forward-looking statements. Astera Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

About Astera Labs
Astera Labs (NASDAQ: ALAB) provides rack-scale AI infrastructure through purpose-built connectivity solutions grounded in open standards. By collaborating with hyperscalers and ecosystem partners, Astera Labs enables organizations to unlock the full potential of modern AI. Astera Labs’ Intelligent Connectivity Platform integrates CXL®, Ethernet, PCIe®, and UALink™ semiconductor-based technologies with the company’s COSMOS software suite to unify diverse components into cohesive, flexible systems that deliver end-to-end scale-up, and scale-out connectivity. Discover more at www.asteralabs.com.

 

 

ASTERA LABS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In thousands)

 

 

 

As of

 

September 30,
2025

 

December 31,
2024

Assets

 

 

 

Current assets

 

 

 

Cash and cash equivalents

$

140,407

 

 

$

79,551

 

Marketable securities

 

994,021

 

 

 

834,750

 

Accounts receivable, net

 

42,898

 

 

 

38,811

 

Inventory

 

51,663

 

 

 

43,215

 

Prepaid expenses and other current assets

 

61,170

 

 

 

16,652

 

Total current assets

 

1,290,159

 

 

 

1,012,979

 

Property and equipment, net

 

72,482

 

 

 

35,651

 

Other assets

 

38,541

 

 

 

5,878

 

Total assets

$

1,401,182

 

 

$

1,054,508

 

 

 

 

 

Liabilities and Stockholders’ Equity

Current liabilities

 

 

 

Accounts payable

$

25,811

 

 

$

26,918

 

Accrued expenses and other current liabilities

 

75,147

 

 

 

59,624

 

Total current liabilities

 

100,958

 

 

 

86,542

 

Other liabilities

 

28,493

 

 

 

3,167

 

Total liabilities

 

129,451

 

 

 

89,709

 

 

 

 

 

Stockholders’ equity

 

 

 

Common stock

 

17

 

 

 

16

 

Additional paid-in capital

 

1,302,261

 

 

 

1,173,153

 

Accumulated other comprehensive income

 

4,097

 

 

 

426

 

Accumulated deficit

 

(34,644

)

 

 

(208,796

)

Total stockholders’ equity

 

1,271,731

 

 

 

964,799

 

Total liabilities and stockholders’ equity

$

1,401,182

 

 

$

1,054,508

 

 

 

 

 

 

 

 

 


ASTERA LABS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In thousands, except per share amounts)

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

September 30,
2025

 

June 30,
2025

 

September 30,
2024

 

September 30,
2025

 

September 30,
2024

Revenue

$

230,575

 

 

$

191,925

 

 

$

113,086

 

 

$

581,942

 

 

$

255,194

 

Cost of revenue

 

54,763

 

 

 

46,362

 

 

 

25,209

 

 

 

141,156

 

 

 

56,943

 

Gross profit

 

175,812

 

 

 

145,563

 

 

 

87,877

 

 

 

440,786

 

 

 

198,251

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

 

Research and development

 

78,928

 

 

 

66,724

 

 

 

50,659

 

 

 

210,206

 

 

 

144,306

 

Sales and marketing

 

19,359

 

 

 

18,609

 

 

 

23,248

 

 

 

59,670

 

 

 

100,834

 

General and administrative

 

22,119

 

 

 

20,456

 

 

 

22,866

 

 

 

64,445

 

 

 

69,321

 

Total operating expenses

 

120,406

 

 

 

105,789

 

 

 

96,773

 

 

 

334,321

 

 

 

314,461

 

Operating income (loss)

 

55,406

 

 

 

39,774

 

 

 

(8,896

)

 

 

106,465

 

 

 

(116,210

)

Interest income

 

11,456

 

 

 

10,885

 

 

 

10,912

 

 

 

32,773

 

 

 

23,730

 

Income (loss) before income taxes

 

66,862

 

 

 

50,659

 

 

 

2,016

 

 

 

139,238

 

 

 

(92,480

)

Income tax (benefit) provision

 

(24,252

)

 

 

(560

)

 

 

9,609

 

 

 

(34,914

)

 

 

15,654

 

Net income (loss)

$

91,114

 

 

$

51,219

 

 

$

(7,593

)

 

$

174,152

 

 

$

(108,134

)

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share attributable to common stockholders:

 

 

 

 

Basic

$

0.54

 

 

$

0.31

 

 

$

(0.05

)

 

$

1.05

 

 

$

(0.89

)

Diluted

$

0.50

 

 

$

0.29

 

 

$

(0.05

)

 

$

0.97

 

 

$

(0.89

)

Weighted-average shares used in calculating net income (loss) per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

Basic

 

167,436

 

 

 

165,428

 

 

 

156,831

 

 

 

165,365

 

 

 

121,649

 

Diluted

 

180,631

 

 

 

178,100

 

 

 

156,831

 

 

 

178,961

 

 

 

121,649

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


ASTERA LABS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In thousands)

 

 

 

Nine Months Ended
September 30,

 

2025

 

2024

Cash flows from operating activities

 

 

 

Net income (loss)

$

174,152

 

 

$

(108,134

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities

 

 

 

Stock-based compensation

 

118,659

 

 

 

186,370

 

Depreciation and amortization

 

3,983

 

 

 

2,180

 

Non-cash operating lease expense

 

2,290

 

 

 

1,687

 

Warrants contra revenue

 

4,016

 

 

 

946

 

Accretion of discounts on marketable securities

 

(6,278

)

 

 

(4,931

)

Other, net

 

231

 

 

 

1,014

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable, net

 

(4,089

)

 

 

(17,054

)

Inventory

 

(7,106

)

 

 

(1,271

)

Prepaid expenses and other assets

 

(56,760

)

 

 

(4,998

)

Accounts payable

 

(1,088

)

 

 

11,723

 

Accrued expenses and other liabilities

 

(624

)

 

 

31,094

 

Operating lease liability

 

(3,345

)

 

 

(1,653

)

Net cash provided by operating activities

 

224,041

 

 

 

96,973

 

 

 

 

 

Cash flows from investing activities

 

 

 

Purchases of property and equipment

 

(18,855

)

 

 

(18,797

)

Purchases of marketable securities

 

(664,432

)

 

 

(724,921

)

Sales and maturities of marketable securities

 

515,109

 

 

 

77,577

 

Other investing activities

 

(500

)

 

 

 

Net cash used in investing activities

 

(168,678

)

 

 

(666,141

)

 

 

 

 

Cash flows from financing activities

 

 

 

Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions

 

 

 

 

672,198

 

Payment of deferred offering costs

 

 

 

 

(4,801

)

Tax withholding related to net share settlements of restricted stock units

 

 

 

 

(20,111

)

Proceeds from exercises of stock options, net of repurchases

 

1,730

 

 

 

2,901

 

Proceeds from employee stock purchase plan

 

4,345

 

 

 

 

Net cash provided by financing activities

 

6,075

 

 

 

650,187

 

Net increase in cash, cash equivalents, and restricted cash

 

61,438

 

 

 

81,019

 

Cash, cash equivalents, and restricted cash

 

 

 

Beginning of the period

 

80,044

 

 

 

45,098

 

End of the period

$

141,482

 

 

$

126,117

 

 

 

 

 

 

 

 

 


ASTERA LABS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (Unaudited)
(In thousands, except percentages and per share amounts)

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

September 30,
2025

 

June 30,
2025

 

September 30,
2024

 

September 30,
2025

 

September 30,
2024

GAAP gross profit

$

175,812

 

 

$

145,563

 

 

$

87,877

 

 

$

440,786

 

 

$

198,251

 

Stock-based compensation expense upon IPO(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

516

 

Stock-based compensation expense

 

379

 

 

 

353

 

 

 

102

 

 

 

694

 

 

 

198

 

Non-GAAP gross profit

$

176,191

 

 

$

145,916

 

 

$

87,979

 

 

$

441,480

 

 

$

198,965

 

 

 

 

 

 

 

 

 

 

 

GAAP gross margin

 

76.2

%

 

 

75.8

%

 

 

77.7

%

 

 

75.7

%

 

 

77.7

%

Stock-based compensation expense upon IPO(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

0.2

 

Stock-based compensation expense

 

0.2

 

 

 

0.2

 

 

 

0.1

 

 

 

0.1

 

 

 

0.1

 

Non-GAAP gross margin(2)

 

76.4

%

 

 

76.0

%

 

 

77.8

%

 

 

75.9

%

 

 

78.0

%

 

 

 

 

 

 

 

 

 

 

GAAP operating income (loss)

$

55,406

 

 

$

39,774

 

 

$

(8,896

)

 

$

106,465

 

 

$

(116,210

)

Stock-based compensation expense upon IPO(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

88,873

 

Stock-based compensation expense

 

40,739

 

 

 

35,474

 

 

 

45,535

 

 

 

118,659

 

 

 

97,497

 

Employer payroll tax related to stock-based compensation from IPO(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

1,072

 

Non-GAAP operating income

$

96,145

 

 

$

75,248

 

 

$

36,639

 

 

$

225,124

 

 

$

71,232

 

 

 

 

 

 

 

 

 

 

 

GAAP operating margin

 

24.0

%

 

 

20.7

%

 

(7.9)%

 

 

18.3

%

 

(45.5)%

Stock-based compensation expense upon IPO(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

34.8

 

Stock-based compensation expense

 

17.7

 

 

 

18.5

 

 

 

40.3

 

 

 

20.4

 

 

 

38.2

 

Employer payroll tax related to stock-based compensation from IPO(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

0.4

 

Non-GAAP operating margin

 

41.7

%

 

 

39.2

%

 

 

32.4

%

 

 

38.7

%

 

 

27.9

%

 

 

 

 

 

 

 

 

 

 

GAAP net income (loss)

$

91,114

 

 

$

51,219

 

 

$

(7,593

)

 

$

174,152

 

 

$

(108,134

)

Stock-based compensation expense upon IPO(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

88,873

 

Stock-based compensation expense

 

40,739

 

 

 

35,474

 

 

 

45,535

 

 

 

118,659

 

 

 

97,497

 

Employer payroll tax related to stock-based compensation from IPO(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

1,072

 

Income tax effect(4)

 

(43,627

)

 

 

(8,670

)

 

 

2,340

 

 

 

(66,935

)

 

 

(2,471

)

Non-GAAP net income

$

88,226

 

 

$

78,023

 

 

$

40,282

 

 

$

225,876

 

 

$

76,837

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share attributable to common stockholders:

 

 

 

 

GAAP - basic

$

0.54

 

 

$

0.31

 

 

$

(0.05

)

 

$

1.05

 

 

$

(0.89

)

GAAP - diluted

$

0.50

 

 

$

0.29

 

 

$

(0.05

)

 

$

0.97

 

 

$

(0.89

)

Non-GAAP pro forma -diluted

$

0.49

 

 

$

0.44

 

 

$

0.23

 

 

$

1.26

 

 

$

0.46

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares used to compute net income (loss) per share attributable to common stockholders:

GAAP - basic

 

167,436

 

 

 

165,428

 

 

 

156,831

 

 

 

165,365

 

 

 

121,649

 

GAAP - diluted

 

180,631

 

 

 

178,100

 

 

 

156,831

 

 

 

178,961

 

 

 

121,649

 

Non-GAAP pro forma - diluted(5)

 

180,631

 

 

 

178,100

 

 

 

173,832

 

 

 

178,961

 

 

 

165,463

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

____________________

(1) Stock-based compensation expense recognized in connection with the time-based vesting and settlement of RSUs that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

(2) Total may not sum due to rounding

(3) Employer payroll taxes related to the time-based vesting and settlement of RSUs, that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

(4) Income tax effect is calculated based on the tax laws in the jurisdictions in which we operate and is calculated to exclude the impact of stock-based compensation expense and one-off discrete tax adjustments that are unrelated to our core operating performance. We no longer maintain valuation allowance for non-GAAP purposes due to our profitability on a non-GAAP basis. For the three months ended September 30, 2025, June 30, 2025, and September 30, 2024, the non-GAAP tax expense rate was approximately 18%, 9%, and 15%, respectively. For the nine months ended September 30, 2025 and 2024, the non-GAAP tax expense rate was approximately 12% and 19%, respectively.

(5) We present the non-GAAP pro-forma weighted average shares to provide meaningful supplemental information of comparable shares for each period presented. The non-GAAP pro forma weighted average shares is calculated as follows:

 

Three Months Ended

 

Nine Months Ended

 

September 30,
2025

 

June 30,
2025

 

September 30,
2024

 

September 30,
2025

 

September 30,
2024

Shares used to compute GAAP net income (loss) per share attributable to common stockholders - diluted

180,631

 

178,100

 

156,831

 

178,961

 

121,649

Weighted average effect of the assumed conversion of redeemable convertible preferred stock from the beginning of the periods

 

 

 

 

25,809

Effect of dilutive equivalent shares

 

 

17,001

 

 

18,005

Shares used to compute non-GAAP pro forma net income per share - diluted

180,631

 

178,100

 

173,832

 

178,961

 

165,463

 

 

 

 

 

 

 

 

 

 


ASTERA LABS, INC.,

RECONCILIATION OF GAAP TO NON-GAAP OUTLOOK (Unaudited)
(In millions, except percentages and per share amounts)

 

 

 

Outlook for Three Months Ending
December 31, 2025

 

Low

 

High

GAAP gross margin

 

75

%

 

 

75

%

Stock-based compensation expense

 

 

 

 

 

Non-GAAP gross margin

 

75

%

 

 

75

%

 

 

 

 

GAAP operating expense

$

129

 

 

$

134

 

Stock-based compensation expense

 

44

 

 

 

44

 

Non-GAAP operating expense

$

85

 

 

$

90

 

 

 

 

 

GAAP tax rate

 

45

%

 

 

45

%

Income tax effect

 

(30

)

 

 

(30

)

Non-GAAP tax rate

 

15

%

 

 

15

%

 

 

 

 

GAAP EPS - diluted

$

0.20

 

 

$

0.20

 

Stock-based compensation expense and income tax effect

 

0.31

 

 

 

0.31

 

Non-GAAP EPS - diluted

$

0.51

 

 

$

0.51

 

 

 

 

 


ASTERA LABS, INC.

 SUPPLEMENTAL FINANCIAL INFORMATION

 STOCK-BASED COMPENSATION EXPENSE (Unaudited)
(In thousands)

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

September 30,
2025

 

June 30,
2025

 

September 30,
2024

 

September 30,
2025

 

September 30,
2024

Cost of revenue

$

379

 

 

$

353

 

 

$

102

 

 

$

694

 

 

$

714

 

Research and development

 

21,711

 

 

 

17,852

 

 

 

14,641

 

 

 

58,749

 

 

 

57,619

 

Sales and marketing

 

9,361

 

 

 

9,194

 

 

 

16,200

 

 

 

30,874

 

 

 

81,216

 

General and administrative

 

9,288

 

 

 

8,075

 

 

 

14,592

 

 

 

28,342

 

 

 

46,821

 

Total stock-based compensation expense (1)

$

40,739

 

 

$

35,474

 

 

$

45,535

 

 

$

118,659

 

 

$

186,370

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

____________________

(1) Stock-based compensation expense recognized during the nine months ended September 30, 2024 included $88.9 million of cumulative stock-based compensation expense related to the time-based vesting and settlement of RSUs that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO.

IR CONTACT: Leslie Green
leslie.green@asteralabs.com